High bodily levels of nickel and selenium may lower pancreatic cancer risk

December 19, 2011

High bodily levels of the trace elements nickel and selenium may lower the risk of developing the most common type of pancreatic cancer, finds research published online in Gut.

Similarly, high levels of lead, arsenic, and cadmium could boost the likelihood of developing the disease, the study shows.

The researchers assessed 12 trace element levels in the toenails of 118 patients with exocrine pancreatic cancer--the most common form of the disease--and just under 400 hospital patients without cancer.

Nails, and particularly toenails, are considered reliable indicators of trace element levels, rather than dietary assessment, because they capture intake/exposure from other sources over the long term.

Analysis of the nail content showed that levels of certain trace elements were significantly higher or lower among the cancer patients than among patients in the comparison group. The higher or lower the level, the greater or lesser was the risk of having the disease.

Patients with the highest levels of arsenic and cadmium in their nails were between two and 3.5 times more likely to have pancreatic cancer than those with the lowest levels.

And those with the highest levels of lead were more than 6 times as likely to have the disease.

On the other hand, those with the highest levels of nickel and selenium were between 33% and 95% less likely to have the disease compared with those with the lowest levels.

These findings held true even after taking account of other known risk factors, such as diabetes, overweight, and smoking.

Smoking is thought to account for around a third of all cases of pancreatic cancer. Tobacco contains trace metals, including cadmium, which is a known cancer causing agent, and has been associated with an increased risk of lung, kidney, and prostate cancers.

High levels of selenium, on the other hand, have been associated with conferring protection against certain cancers, and previous research indicates that selenium may counter the harmful effects of cadmium, arsenic, and lead.

The authors point out that despite decades of research, the causes of pancreatic cancer remain largely unknown: "Our results support an increased risk of pancreatic cancer associated with higher levels of cadmium, arsenic, and lead, as well as an inverse association with higher levels of selenium and nickel," they conclude.

"These novel findings, if replicated in independent studies, would point to an important role of trace elements in pancreatic carcinogenesis."
-end-
Notes for editors:

Gut is one of more than 35 specialist titles published by BMJ Group. It is co-owned with the British Society for Gastroenterology. www.gut.bmj.com

BMJ

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.